These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23475633)

  • 1. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
    Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL
    Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study.
    Li H; Zhou RJ; Zhang GQ; Xu JP
    Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
    Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
    Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
    Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
    Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
    Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
    Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
    Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of annexin II expression in human non-small cell lung cancer.
    Jia JW; Li KL; Wu JX; Guo SL
    Tumour Biol; 2013 Jun; 34(3):1767-71. PubMed ID: 23494179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W; Jiang WY; Chen WS; Sun W; Fu XN
    Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic roles of TRPV5 and TRPV6 in non-small cell lung cancer after curative resection.
    Fan H; Shen YX; Yuan YF
    Asian Pac J Cancer Prev; 2014; 15(6):2559-63. PubMed ID: 24761864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
    Zhang Y; Ma M; Han B
    Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
    Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
    Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis.
    Huang AL; Liu SG; Qi WJ; Zhao YF; Li YM; Lei B; Sheng WJ; Shen H
    Asian Pac J Cancer Prev; 2014; 15(19):8143-7. PubMed ID: 25338997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.
    Zhang J; Chen N; Qi J; Zhou B; Qiu X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1441-9. PubMed ID: 24770635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of annexin II expression in non-small cell lung cancer.
    Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF
    Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.